CSNK1A1 Human

Casein Kinase 1 alpha 1 Human Recombinant
Cat. No.
BT29913
Source
E.coli.
Synonyms
Casein kinase I isoform alpha, CKI-alpha, CK1, CSNK1A1, HLCDGP1, PRO2975.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 80% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CSNK1A1 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 357 amino acids (1-337) and having a molecular mass of 41kDa. CSNK1A1 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Caseine Kinase 1 alpha, a member of the protein kinase superfamily, CK1 Ser/Thr protein kinase family, and Casein kinase I subfamily, plays a crucial role in various cellular processes. Its isoforms, including alpha, beta, gamma, delta, epsilon, and their splice variants, are involved in membrane trafficking, circadian rhythm regulation, cell cycle progression, chromosome segregation, apoptosis, and cellular differentiation. CSNK1A1 is believed to phosphorylate numerous proteins and participates in Wnt signaling by phosphorylating CTNNB1 on Ser45. Additionally, it interacts with the Axin complex.
Description
Recombinant human CSNK1A1, expressed in E.coli, is a non-glycosylated polypeptide chain with a molecular weight of 41kDa. This protein consists of 357 amino acids (1-337), including a 20 amino acid His-tag fused at the N-terminus. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The CSNK1A1 solution is provided at a concentration of 0.5mg/ml in a buffer containing 20mM Tris-HCl (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of the CSNK1A1 protein is greater than 80% as determined by SDS-PAGE analysis.
Synonyms
Casein kinase I isoform alpha, CKI-alpha, CK1, CSNK1A1, HLCDGP1, PRO2975.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MASSSGSKAE FIVGGKYKLV RKIGSGSFGD IYLAINITNG EEVAVKLESQ KARHPQLLYE SKLYKILQGG VGIPHIRWYG QEKDYNVLVM DLLGPSLEDL FNFCSRRFTM KTVLMLADQM ISRIEYVHTK NFIHRDIKPD NFLMGIGRHC NKLFLIDFGL AKKYRDNRTR QHIPYREDKN LTGTARYASI NAHLGIEQSR RDDMESLGYV LMYFNRTSLP WQGLKAATKK QKYEKISEKK MSTPVEVLCK GFPAEFAMYL NYCRGLRFEE APDYMYLRQL FRILFRTLNH QYDYTFDWTM LKQKAAQQAA SSSGQGQQAQ TPTGKQTDKT KSNMKGF.

Product Science Overview

Introduction

Casein Kinase 1 Alpha 1 (CK1α1) is a serine/threonine protein kinase that belongs to the Casein Kinase 1 (CK1) family. This enzyme is encoded by the CSNK1A1 gene in humans and is involved in various cellular processes, including membrane trafficking, cell cycle progression, chromosome segregation, apoptosis, autophagy, cell metabolism, differentiation, circadian rhythm, immune response, neurodegeneration, and cancer .

Structure and Isoforms

CK1α1 is expressed as four alternatively spliced transcript variants, resulting in four protein isoforms of varying lengths. These isoforms mainly differ by the presence or absence of a 28-amino acid “L” insert in the kinase domain and a 12-amino acid “S” insert near the C terminus . The recombinant form of CK1α1 is often produced using baculovirus expression systems in insect cells, with an N-terminal GST tag for purification and stability .

Biological Functions

CK1α1 plays a crucial role in several signaling pathways, most notably the Wnt/β-catenin signaling pathway. It phosphorylates β-catenin at Ser45, which is part of the β-catenin destruction complex, leading to β-transducin repeat-containing E3 ubiquitin protein ligase (β-TrCP)-mediated ubiquitination and proteasomal degradation . Additionally, CK1α1 targets the tumor suppressor protein p53 for degradation, mediated by murine double minute clone 2 (MDM2) and MDM4 (also known as MDMX), while stabilizing and positively regulating the transcription factor E2F-1, which is involved in cell cycle progression .

Clinical Significance

CK1α1 is a promising therapeutic target due to its involvement in diverse cellular, physiological, and pathological processes. For instance, lenalidomide, a thalidomide analog, is an effective treatment for myelodysplastic syndrome with deletion of chromosome 5q [MDS del (5q)], exerting its effects by inducing CK1α1 ubiquitination and degradation . This suggests that CSNK1A1 is a conditionally essential malignancy gene and a potential target for anti-cancer drugs .

Recombinant Production and Applications

Recombinant human CK1α1 is produced using baculovirus expression systems in insect cells, with an N-terminal GST tag for purification and stability . The recombinant protein is used in various research applications, including studies on cell signaling, cancer research, and drug development. It is supplied in a sterile buffer and should be stored at –70°C to maintain its stability and activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.